Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock Discusses New CRISPR IP Alliance

December 19, 2016  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Some Consensus in the CRISPR Patent Case,” an article published in MedCity News. The article discuses four companies founded in the CRISPR space that announced last Friday, December 16, that they had formed an IP alliance.

Read the article here

 

Related Links

Industries

News & Insights

News
Jun 2025
Stephen Larson Discusses SEP-Related Antitrust Suits With IAM
Knobbe Martens partner Stephen Larson was quoted in the IAM article, “Even frivolous FRAND-related antitrust actions risk hurting SEP holders,” regarding the ongoing dispute between Samsung and ZTE Corp. over...
Blog - Podcast
Jun 2025
AI and Copyright: Navigating the Legal Maze with Liz Rothman
In this episode of Knobbe IP+, Knobbe Martens partner Mark Lezama is joined by attorney and emerging technology advisor Liz Rothman to discuss the complex topic of artificial intelligence and...
News
Jun 2025
Knobbe Martens, Dozens of Firm Partners Recognized in Legal 500 U.S.A. Guide
Firm again receives standout rankings in multiple practice areas, including prosecution, trademarks, licensing, and litigation IRVINE, Calif., June 17, 2025 – Knobbe Martens is proud to announce that the firm...